Most users report no side effects
More common (about 18%) is for frequent amphetamine users to report psychotic symptoms that are sub-clinical and that do not require high-intensity intervention
Patients over 50 starting GLP-1 therapy should discuss bone health monitoring with their provider, ensure adequate calcium and vitamin D intake, and incorporate weight-bearing exercise into their routine
BPC-157 peptide therapy may be suitable for adults seeking relief from musculoskeletal pain or injuries, joint concerns, digestive issues, chronic inflammation, or central nervous system (CNS) disorders.8 11 It could also potentially be used for neuroprotection, nerve regeneration, repairing organ damage from substance overdoses, healing lesions, and more.7 However, its again important to reiterate that nearly all of the above potential benefits of BPC-157 have not been demonstrated in human studies or trials
(2018) observed a decrease in body weight and hepatic lipid accumulation in Dawley rats fed with the water kefir consisting of Liquorilactobacillus mali APS1 isolated from water kefir grain